Adebayo Alonge, a Nigerian Pharmacist has won the 2019 deepTech Challenge at the Hello Tomorrow conference in Paris.
Bayo Beats 4,500 From 119 Countries to Win €100,000 Prize for His Anti-Fake Drugs Startup. He co-developed a miniature nanoscanner that uses AI to identify fake drugs and assess general drug quality on mobile phones.
Starting at $60/month, pharmacovigilance inspectors from country FDAs can now use the RxAll solution to test drug quality at the ports and in pharmacies using their phones.
They can also use the RxAll solution to see where bad drugs are showing up in different cities and who is responsible in real time. Doing so, they can organise batch recalls and stop the bad actors in real time.
Hello Tomorrow is one of the world’s best deepTech conference for scientists, technologists and their enablers”.
It organises an annual challenge that seeks to identify the best deepTech solution in the world, over a six-month period.
The conference seeks to discover, initiate and support the deepTech ecosystem, the purpose of which is to scale science-based solutions to solve the world’s biggest problems.
Alonge credits his science education at King’s College Lagos and at the Pharmacy School, University of Ibadan, for providing the building blocks of this innovative technology.
In the 2019 deepTech challenge, 4,500 deepTech startups applied from across 119 countries. A global jury of the best deepTech scientists and investors reviewed the applications, selected the top 500 deepTech applicants and organised regional pitch contests to select the Top 80 finalists for the finals in Paris in March 2019.
Alonge’s startup RxAll was drawn into the Africa region finals in Cape Town, which was organised by the @africarena. RxAll won this regional final in November 2018, worth a $5,000 prize money and associated AI benefits from Microsoft.